Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HMGCR | P04035 | 1/20 | 0.67 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.67 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.67 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.67 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.44 |
| ▸ | CPT2 | P23786 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28085842 | 0.86 | HMGCR (0.61) | HMGCRCHRM1TBXA2RADRA1AFFAR1 | |
| SCHEMBL17956708 | 0.84 | HMGCR (0.46) | HMGCRCHRM1TBXA2RADRA1AFFAR1 | |
| SCHEMBL9242668 | 0.82 | HMGCR (0.56) | HMGCRCHRM1TBXA2RADRA1AFFAR1 | |
| Meglutol SCHEMBL28443 | 0.81 | HMGCR (1.00) | HMGCRCHRM1TBXA2RADRA1AFFAR1 | |
| Meglutol SCHEMBL8718194 | 0.81 | HMGCR (1.00) | HMGCRCHRM1TBXA2RADRA1AFFAR1 | |
| SCHEMBL31117460 | 0.81 | HMGCR (0.54) | HMGCRCHRM1TBXA2RADRA1AFFAR1 | |
| Mevalonic Acid SCHEMBL120276 | 0.80 | HMGCR (0.67) | HMGCRCHRM1TBXA2RADRA1AFFAR1 | |
| Mevalonic Acid SCHEMBL120275 | 0.80 | HMGCR (0.67) | HMGCRCHRM1TBXA2RADRA1AFFAR1 | |
| SCHEMBL333179 | 0.80 | HMGCR (0.67) | HMGCRCHRM1TBXA2RADRA1AFFAR1 | |
| Mevalonic Acid SCHEMBL8854071 | 0.80 | HMGCR (0.67) | HMGCRCHRM1TBXA2RADRA1AFFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220162148-A1 | METHOD OF PRODUCING ALPHA,BETA-UNSATURATED DICARBOXYLIC ACID ESTER | TORAY INDUSTRIES, INC. (JP) | 2022-05-26 | — | — | US | disclosed |
| CN-111809068-B | Preparation method of ammonium metavanadate for all-vanadium redox flow battery | 中国科学院过程工程研究所 | 2020-12-15 | — | — | CN | disclosed |
| CN-111809068-A | Preparation method of ammonium metavanadate for all-vanadium redox flow battery | 中国科学院过程工程研究所 | 2020-10-23 | — | — | CN | disclosed |
| US-5214049-A | Blend of polyphenylene ether, thermoplastic polyester and a hydroxycarboxylic acid or derivative; workability; solvent resistance; mechanical properties | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1993-05-25 | — | — | US | disclosed |
| EP-0368283-A2 | Resin composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1990-05-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220162148-A1 | METHOD OF PRODUCING ALPHA,BETA-UNSATURATED DICARBOXYLIC ACID ESTER | DHCR24, ACADM, DHCR7 | HMGCR 20/4885CHRM1 1914/4885TBXA2R 3634/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.